Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
10/17/2025
LEO Pharma's Anzupgo Cream NDA Accepted in China
10/17/2025
RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
10/16/2025
Belite Bio Secures Priority Review from China's NMPA for Tinlarebant
10/16/2025
Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016
10/15/2025
Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
10/14/2025
GSK's Shingrix Wins Chinese Approval for Expanded Use
10/14/2025
Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
10/14/2025
Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...
10/14/2025
AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...
10/13/2025
Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
10/13/2025
Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
10/13/2025
Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...
10/13/2025
Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
10/13/2025
Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315
10/13/2025
4B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...
10/13/2025
Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
10/13/2025
Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
10/13/2025
USB's Zilbrysq Wins Chinese Approval
10/13/2025
CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials
10/3/2025
Santen and RemeGen Files Chinese BLA for RC28-E
10/3/2025
Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
9/25/2025
SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
9/24/2025
NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
9/24/2025
Fosun Kairui Submits Marketing Application for Brexucabtagene Autoleuc...
9/23/2025
Leads Biolabs' LBL-047 Wins FDA Clearance, Advances Toward Clinical Tr...
9/23/2025
KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
9/23/2025
IASO Bio Presents 36-Month Data for Fucaso
9/22/2025
Ascletis' ASC47 Combined with Semaglutide Shows Superior Weight Loss a...
9/22/2025
MagicRNA Publishes First-in-Human Data for In Vivo CAR-T Therapy in SL...
9/22/2025
Leads Biolabs Wins FDA Clearance for IND of LBL-047
Page:
1
/
20
Total number of articles:
583
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit